Melanoma metastases in regional lymph nodes are accurately detected by proton magnetic resonance spectroscopy of fine-needle aspirate biopsy samples

Annals of Surgical Oncology

Volumn 12, Issue 11, 2005, Pages 943-949

  Stretch, Jonathan R ^a,b   Somorjai, Ray ^c   Bourne, Roger ^b   Hsiao, Edward ^b   Scolyer, Richard A ^a   Dolenko, Brion ^c   Thompson, John F ^a,b   Mountford, Carolyn E ^b   Lean, Cynthia L ^b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Cancer; Lymph node metastases; Magnetic resonance spectroscopy; Melanoma; Statistical classification strategy

Indexed keywords

PROTON;

ARTICLE; ASPIRATION BIOPSY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DISCRIMINANT ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MELANOMA; PREDICTION; PROTON NUCLEAR MAGNETIC RESONANCE; REPRODUCIBILITY; SENTINEL LYMPH NODE BIOPSY;

BIOPSY, FINE-NEEDLE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE SPECTROSCOPY; MELANOMA; PROTONS; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 24044551083     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/ASO.2005.03.073     Document Type: Article

References (34)

1. Thompson JF, Uren RF. Lymphatic mapping and sentinel node biopsy for melanoma. Exp Rev Anticancer Ther 2001;1:446-52.
2. Thompson JF, McCarthy WH, Bosch CM, et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 1995;5:255-60.
3. Mountford CE, Doran S, Lean CL, Russell P. Cancer pathology in the year 2000. Biophys Chem 1997;68:127-35.
4. Somorjai R, Dolenko B, Nikulin A, et al. Distinguishing normal allografts from biopsy-proven rejections: application of a three-stage classification strategy to urine MR and IR spectra. Vibr Spectrosc 2002;28:97-102.
5. Lean CL, Somorjai RL, Smith ICP, Russell P, Mountford CE. Accurate diagnosis and prognosis of human cancers by proton MRS and a three-stage classification strategy. In: Webb GA, ed. Annual Reports on NMR Spectroscopy, Volume 48. Guildford, UK: Academic Press, 2002: 71-111.
6. 't Hart B, Vogels J, Spijksma G, Brok H, Polman C, van der Greef J. 1H-NMR spectroscopy combined with pattern recognition analysis reveals characteristic chemical patterns in urines of MS patients and non-human primates with MS-like disease. J Neurol Sci 2003;212:21-30.
7. Rush D, Somorjai R, Deslauriers R, Shaw A, Jeffery J, Nickerson P. Subclinical rejection - a potential surrogate marker for chronic rejection - may be diagnosed by protocol biopsy or urine spectroscopy. Ann Transplant 2000;5:44-9.
8. Swanson MG, Vigneron DB, Tran TK, Kurhanewicz J. Magnetic resonance imaging and spectroscopic imaging of prostate cancer. Cancer Invest 2001;19:510-23.
9. Lean C, Bourne R, Thompson J, et al. Rapid detection of metastatic melanoma in lymph nodes using proton magnetic resonance spectroscopy of fine needle aspiration biopsy specimens. Melanoma Res 2003;13:259.
10. Reo NV. NMR-based metabonomics. Drug Chem Toxicol 2002;25:375-82.
11. Hagberg G. From magnetic resonance spectroscopy to classification of tumours. A review of pattern recognition methods. N M R Biomed 1998;11:148-56.
12. El-Deredy WA. Pattern recognition approaches in biomedical and clinical magnetic resonance spectroscopy. N M R Biomed 1997;10:99-124.
13. Doran S, Falk G, Somorjai R, et al. Pathology of Barrett's oesophagus by proton magnetic resonance spectroscopy and a statistical classification strategy. Am J Surg 2003;185:232-8.
14. Braun S, Kalinowski HO, Berger S. 150 and More Basic NMR Experiments: A Practical Course. 2nd ed. Weinheim, Germany: Wiley-VCH, 1998.
15. Li XL, Scolyer RA, Ka VSK, et al. Pathological review of negative sentinel lymph nodes in patients with regional recurrence of melanoma: a clinicopathologic review of 1170 cutaneous melanoma patients undergoing sentinel lymph node biopsies, including recommendations for the pathological examination of sentinel lymph nodes. Am J Surg Pathol 2003;27:1197-202.
16. Mountford C, Lean C, Hancock R, et al. Magnetic resonance spectroscopy detects cancer in draining lymph nodes. Invasion Metastasis 1993;13:57-71.
17. Lean CL, Mackinnon WB, Delikatny EJ, Whitehead RH, Mountford CE. Cell-surface fucosylation and magnetic resonance spectroscopy characterization of human malignant colorectal cells. Biochemistry 1992;31:11095-105.
18. Mackinnon WB, Huschtscha L, Dent K, Hancock R, Paraskeva C, Mountford CE. Correlation of cellular differentiation in human colorectal carcinoma and adenoma cell lines with metabolite profiles determined by 1H magnetic resonance spectroscopy. Int J Cancer 1994;59:248-61.
19. Mountford CE, Somorjai RL, Malycha P, et al. Diagnosis and prognosis of breast cancer by magnetic resonance spectroscopy of fine-needle aspirates analysed using a statistical classification strategy. Br J Surg 2001;88:1234-40.
20. Delikatny EJ, Russell P, Hunter JC, et al. Proton MR and human cervical neoplasia 1: ex vivo spectroscopy allows distinction of invasive carcinoma of the cervix from carcinoma in situ and other preinvasive lesions. Radiology 1993;188:791-6.
21. Mackinnon WB, May GL, Mountford CE. Esterified cholesterol and triglyceride are present in plasma membranes of Chinese hamster ovary cells. Eur J Biochem 1992;205:827-39.
22. Kuesel AC, Kroft T, Saunders JK, Prefontaine M, Mikhael N, Smith IC. A simple procedure for obtaining high-quality NMR spectra of semiquantitative value from small tissue specimens: cervical biopsies. Magn Reson Med 1992;27:349-55.
23. Russell P, Lean CL, Delbridge L, May GL, Dowd S, Mountford CE. Proton magnetic resonance, human thyroid neoplasia. I: Discrimination between benign and malignant neoplasms. Am J Med 1994;96:383-8.
24. Delbridge L, Lean C, Russell P, et al. Proton magnetic resonance and human thyroid neoplasms: potential avoidance of surgery for benign follicular neoplasms. World J Surg 1994;18:512-7.
25. Lean CL, Delbridge L, Russell P, et al. Diagnosis of follicular thyroid lesions by proton magnetic resonance on fine needle biopsy. J Clin Endocrinol Metab 1995;80:1306-11.
26. Lean CL, Newland RC, Ende DA, Bokey EL, Smith IC, Mountford CE. Assessment of human colorectal biopsies by 1H MRS. correlation with histopathology. Magn Reson Med 1993;30:525-33.
27. Mackinnon WB, Russell P, May GL, Mountford CE. Characterisation of human ovarian epithelial tumours (ex vivo) by proton magnetic resonance spectroscopy. Int J Gynaecol Cancer 1995;5:211-21.
28. Hahn P, Smith ICP, Leboldus L, Littman C, Somorjai RL, Bezabeh T. The classification of benign and malignant human prostate tissue by multivariate analysis of H-1 magnetic resonance spectra. Cancer Res 1997;57:3398-401.
29. Mackinnon WB, Barry PA, Malycha PL, et al. Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy. Radiology 1997;204:661-6.
30. Bezabeh T, Smith IC, Krupnik E, et al. Diagnostic potential for cancer via 'H magnetic resonance spectroscopy of colon tissue. Anticancer Res 1996;16:1553-8.
31. Bezabeh T, Samy E, Patel R, et al. Statistical classification strategy for proton magnetic resonance spectra of soft tissue sarcoma: an exploratory study with potential clinical utility. Sarcoma 2002;6:97-103.
32. Dawson M, Doble P, Beavis A, Li LX, Soper R, Scolyer RA. Antimony by ICP-MS as a marker for sentinel lymph nodes in melanoma patients. Analyst 2003;128:217-9.
33. Scolyer RA, Thompson JF, Li LXL, et al. Antimony concentrations in nodal tissue can confirm sentinel node identity. Mod Pathol 2004;17:1191-7.
34. Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001;19:3622-34.